ConclusionsCompared with placebo, buprenorphine implants result in significantly less frequent opioid use, and are non‐inferior to sublingual buprenorphine/naloxone tablets. (Source: Addiction)
MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.